Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction

被引:3
|
作者
Olivero-Verbel, Jesus [1 ,3 ]
Harkema, Jack R. [2 ]
Roth, Robert A. [1 ]
Ganey, Patricia E. [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, 1129 Farm Lane,Room 214,Food Safety & Toxicol Bld, E Lansing, MI 48824 USA
[2] Michigan State Univ, Inst Integrat Toxicol, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA
[3] Univ Cartagena, Sch Pharmaceut Sci, Environm & Computat Chem Grp, Cartagena 130014, Colombia
关键词
Inflammation; Liver; Apoptosis; PPAR; Il-6; TNF; FATTY LIVER-DISEASE; NECROSIS-FACTOR-ALPHA; EPITHELIAL-CELL LINE; PPAR-ALPHA; NONALCOHOLIC STEATOHEPATITIS; GENE-EXPRESSION; HEPATIC STEATOSIS; LIPID-METABOLISM; D-GALACTOSAMINE; INJURY;
D O I
10.1016/j.cbi.2021.109521
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2,3,7,8-Tetrachlorodibenzo-p-dioxin (dioxin; TCDD) is an environmental contaminant that elicits a variety of toxic effects, many of which are mediated through activation of the aryl hydrocarbon receptor (AhR). Interaction between AhR and the peroxisome proliferator-activated receptor-alpha (PPAR-alpha), which regulates fatty acid metabolism, has been suggested. Furthermore, with recognition of the prevalence of inflammatory conditions, there is current interest in the potential for inflammatory stress to modulate the response to environmental agents. The aim of this work was to assess the interaction of TCDD with hepatic inflammation modulated by fenofibrate, a PPAR-alpha agonist. Female, C57BL/6 mice were treated orally with vehicle or fenofibrate (250 mg/ kg) for 13 days, and then were given vehicle or 30 mu g/kg TCDD. Four days later, the animals received an i.p. injection of lipopolysaccharide-galactosamine (LPS-GalN) (0.05x10(7) EU/kg and 500 mg/kg, respectively) to incite inflammation, or saline as vehicle control. After 4 h, the mice were euthanized, and blood and liver samples were collected for analysis. Livers of animals treated with TCDD with or without LPS-GalN had increased lipid deposition, and this effect was blocked by fenofibrate. In TCDD/LPS-GalN-treated mice, fenofibrate caused an increase in plasma activity of alanine aminotransferase, a marker of hepatocellular injury. TCDD reduced LPSGalN-induced apoptosis, an effect that was prevented by fenofibrate pretreatment. LPS-GalN induced an increase in the concentration of interleukin-6 in plasma and accumulation of neutrophils in liver. TCDD exposure enhanced the former response and inhibited the latter one. These results suggest that fenofibrate counteracts the changes in lipid metabolism induced by TCDD but increases inflammation and liver injury in this model of inflammation-TCDD interaction.
引用
收藏
页数:9
相关论文
共 31 条
  • [21] Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms
    Liu, Kai
    Zhao, Xing
    Qi, Xue
    Hou, Dong-Liang
    Li, Hao-Bin
    Gu, Yu-Hao
    Xu, Qing-Long
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 218
  • [22] Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression
    Enright, Jennifer M.
    Zhang, Sheng
    Thebeau, Christina
    Siebert, Emily
    Jin, Alexander
    Gadiraju, Veda
    Zhang, Xiaodong
    Chen, Shiming
    Semenkovich, Clay F.
    Rajagopal, Rithwick
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 15
  • [23] Glucose Transporter 4 and Peroxisome Proliferator-Activated Receptor-Alpha Overexpression Association With Cardioprotective Effects of Myoinositol and Metformin Combination in Type 2 Diabetic Rat Model
    Mohamed, Dalia Abdel-Wahab
    Elayat, Wael M.
    Abozeid, Asmaa A.
    Abdel-Salam, Mohamed F.
    Teama, Nahla Mohamed
    Abdelrahim, Dina Sayed
    Tamim, Yomna M.
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 11 (05) : 140 - 151
  • [24] Systemic administration of WY-14643, a selective synthetic agonist of peroxisome proliferator activator receptor-alpha, alters spinal neuronal firing in a rodent model of neuropathic pain
    Okine, Bright N.
    Spicer, Clare
    Millns, Paul
    Bennett, Andrew
    Chapman, Victoria
    SCANDINAVIAN JOURNAL OF PAIN, 2015, 9 : 42 - 48
  • [25] Pioglitazone, a Peroxisome Proliferator-Activated Receptor-? Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in Leishmania braziliensis Killing by Monocytes
    Nascimento, Mauricio T.
    Cordeiro, Ravena S. O.
    Abreu, Cayo
    Santos, Camila P.
    Peixoto, Fabio
    Duarte, Gabriela A.
    Cardoso, Thiago
    de Oliveira, Camila I.
    Carvalho, Edgar M.
    Carvalho, Lucas P.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [26] A peroxisome proliferator-activated receptor-alpha (PPARα) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPARα: implications for species differences in responses to peroxisome proliferators
    Jonathan D. Tugwood
    Peter R. Holden
    Neil H. James
    Rebecca A. Prince
    Ruth A. Roberts
    Archives of Toxicology, 1998, 72 : 169 - 177
  • [27] A peroxisome proliferator-activated receptor-alpha (PPARα) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPARα:: implications for species differences in responses to peroxisome proliferators
    Tugwood, JD
    Holden, PR
    James, NH
    Prince, RA
    Roberts, RA
    ARCHIVES OF TOXICOLOGY, 1998, 72 (03) : 169 - 177
  • [28] A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response:: The PPARα-null mouse as a model of fatty acid oxidation disorders
    Leone, TC
    Weinheimer, CJ
    Kelly, DP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) : 7473 - 7478
  • [29] Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema
    Ozawa, Chihiro
    Horiguchi, Michiko
    Akita, Tomomi
    Oiso, Yuki
    Abe, Kaori
    Motomura, Tomoki
    Yamashita, Chikamasa
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (05) : 778 - 785
  • [30] Combined gemfibrozil (peroxisome proliferator-activated receptor alpha agonist) with reduced steroid dose gives a similar management picture as the full steroid dose in a rat adjuvant-induced arthritis model
    Ashour, Hend
    Rashed, Laila Ahmed
    El-Sebaie, Mohamed Mahmoud
    Sabry, Marwa Mohammed
    Abdelmohsen, Manal Ali
    Eissa, Mervat
    MODERN RHEUMATOLOGY, 2019, 29 (04) : 602 - 611